Lv2
115 积分 2022-06-22 加入
Paclitaxel–HSA interaction. Binding sites on HSA molecule
1个月前
已完结
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma
6个月前
已完结
Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook
6个月前
已完结
Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification
6个月前
已完结
Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial
7个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
8个月前
已完结
Comparative Effectiveness of Paclitaxel‐Containing Regimens for Treatment of Triple‐Negative Breast Cancer: A Network Meta‐Analysis
8个月前
已完结
Long and short-term efficacy and safety comparison of nab-paclitaxel versus paclitaxel combined with trastuzumab and pertuzumab for neoadjuvant treatment of HER2-positive breast cancer: A systematic review and meta-analysis
8个月前
已完结
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
9个月前
已完结
皖公网安备34019202002308
